Phase II Study of Thalidomide Plus Dexamethasone Induction Followed by Tandem Melphalan-Based Autotransplantation and Thalidomide-Plus-Prednisone Maintenance for Untreated Multiple Myeloma: A Southwest Oncology Group Trial (S0204)

PURPOSE: Thalidomide-dexamethasone (THAL-DEX) is standard induction therapy for multiple myeloma (MM). Tandem melphalan-based transplantations have yielded superior results to single transplantations. Phase II trial S0204 was designed to improve survival results reported for the predecessor, phase I...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Hussein, Mohamad A., Bolejack, Vanessa, Zonder, Jeffrey A., Durie, Brian G.M., Jakubowiak, Andrzej J., Crowley, John J., Barlogie, Bart
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2009
Onderwerpen:
Original Reports
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2717757/
https://ncbi.nlm.nih.gov/pubmed/19546405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.19.9240
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items